The RAC-Devices examination is not limited to one regulation or one country.

It covers regulatory responsibilities across the medical device lifecycle.

Candidates should expect the exam to address broad areas such as:

• Regulatory strategy
• Product development
• Premarket requirements
• Clinical and performance evidence
• Quality systems and manufacturing
• Registration and market authorization
• Labeling
• Product changes
• Post-market surveillance
• Regulatory compliance
• Global regulatory practices
• Regulatory operations and lifecycle management

The exam content is refreshed regularly, and RAPS recommends using the current exam content outline rather than relying only on older study materials. The organization also notes that the updated exam focuses on established regulatory practices rather than highly speculative or cutting-edge topics.

---

Domain 1: Regulatory Strategy and Planning

This area evaluates whether the candidate can develop and support an effective regulatory strategy.

Topics may include:

• Identifying target markets
• Determining device classification
• Selecting submission pathways
• Evaluating applicable standards
• Assessing evidence requirements
• Estimating timelines
• Identifying regulatory risks
• Coordinating global market-entry strategies

A regulatory professional should understand how product design decisions affect future market access.

For example, changing an intended use may affect:

• Device classification
• Clinical evidence requirements
• Labeling
• Submission type
• Post-market obligations

This is why RA should be involved early in product development.

---

Domain 2: Product Development and Premarket Activities

This area focuses on regulatory involvement before a product reaches the market.

Candidates may need to understand:

• Intended use and indications
• Product classification
• Design and development controls
• Risk management
• Verification and validation
• Biocompatibility
• Sterilization
• Packaging validation
• Electrical safety
• Software documentation
• Cybersecurity
• Clinical evaluation
• Performance testing
• Technical documentation

The candidate is not expected to perform every engineering or clinical task personally.

However, the regulatory professional must understand which evidence is required and how it supports a regulatory submission.

---

Domain 3: Registration and Market Authorization

This domain may include:

• Submission preparation
• Submission pathways
• Regulatory authority communication
• Technical file or dossier content
• Deficiency responses
• Certificates and declarations
• Local representation
• Product registration
• Approval and clearance conditions

Candidates should understand that different markets use different systems.

For example, a medical device may require:

• FDA clearance or approval in the United States
• Conformity assessment and CE marking in Europe
• Product approval or certification in Korea
• Separate registration in Canada, Japan, Australia, or other countries

The RAC-Devices exam therefore tests global regulatory thinking rather than knowledge of only one national system.

---

Domain 4: Quality Systems and Manufacturing

Regulatory Affairs professionals must understand the relationship between product authorization and the quality system.

Topics may include:

• Quality-management-system requirements
• Manufacturing-site controls
• Supplier controls
• Design controls
• Process validation
• Corrective and preventive action
• Nonconformances
• Audits and inspections
• Record retention
• Change control
• Regulatory commitments

For example, a manufacturing change may be properly approved internally but still require external regulatory notification or approval.

The regulatory professional must identify this connection.

---

Domain 5: Labeling and Promotion

Candidates should understand how labeling relates to the authorized product scope.

This may include:

• Intended use
• Indications
• Contraindications
• Warnings
• Precautions
• Instructions for use
• Symbols
• Unique device identification
• Promotional claims
• Website and advertising review
• Labeling changes

A product claim must generally be supported by evidence and remain consistent with the authorized intended use.

A marketing statement that exceeds the approved scope may create significant regulatory risk.

---

Domain 6: Post-Market Activities

The medical device lifecycle continues after commercial launch.

Post-market topics may include:

• Complaint handling
• Adverse-event reporting
• Vigilance
• Medical device reporting
• Trend analysis
• Post-market surveillance
• Post-market clinical follow-up
• Recalls
• Field safety corrective actions
• Authority communication
• Corrective actions
• Safety signals

Candidates may be asked to determine what should happen after receiving a complaint involving possible patient harm.

The best answer may depend on:

• Severity
• Event outcome
• Device contribution
• Market
• Reporting criteria
• Reporting timeline
• Available evidence
• Risk assessment

---

Domain 7: Product Changes and Lifecycle Management

Medical devices frequently change after approval.

The exam may address changes involving:

• Raw materials
• Components
• Suppliers
• Manufacturing sites
• Equipment
• Software
• Sterilization
• Packaging
• Specifications
• Intended use
• Labeling
• Legal manufacturer information

Candidates should understand how to assess whether a change requires:

• Documentation only
• Regulatory notification
• Prior approval
• Registration amendment
• New submission
• Updated technical documentation

This area is highly relevant for professionals working in both QA and RA